我們已在上線!
進一步了解
Insulet
PODD
PODD
關於: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
員工: 5,400
新聞
正面
中性
負面
市場情緒
3個月
正面
5.8%
中性
92.3%
負面
1.9%
價格圖表採用Lightweight Charts™實作